Kasper S, Foch C, Esser R, Lamy FX, et al. Overall survival with cetuximab every-2-weeks versus standard once-weekly administration schedule for first-line treatment of RAS wild-type metastatic colorectal cancer in patients with left- and right-sided primary tumour location. Eur J Cancer 2022;180:85-88.
PMID: 36563490